deltatrials

Chronic obstructive pulmonary disease (COPD) Trials in Madrid, Spain

Conditions / Chronic obstructive pulmonary disease (COPD) / Madrid, Spain

Chronic obstructive pulmonary disease (COPD) is a medical condition with active clinical research programs worldwide.

24 total trials for this combination

Showing top 10 of 24 trials

Trials

NCT ID Title Status Phase
NCT00297115 Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125) COMPLETED PHASE3
NCT06883305 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006) RECRUITING PHASE3
NCT01782326 QVA vs. Salmeterol/Fluticasone, 52-week Exacerbation Study, FLAME (EFfect of Indacaterol Glycopyronium Vs Fluticasone Salmeterol on COPD Exacerbations) COMPLETED PHASE3
NCT06040086 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations ACTIVE_NOT_RECRUITING PHASE3
NCT06055543 Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients UNKNOWN PHASE4
NCT00877383 Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease COMPLETED PHASE3
NCT05595642 A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease RECRUITING PHASE3
NCT07082738 A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease RECRUITING PHASE2
NCT05742802 Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO). ACTIVE_NOT_RECRUITING PHASE3
NCT05166889 Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations COMPLETED

Related Pages